Svitzer Group A/S
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons
Pursuant to the Market Abuse Regulation, article 19, Svitzer Group A/S, CVR-no. 44 79 14 47, (“Svitzer”) hereby notifies receipt of information of the following transactions made by members of the Board of Directors or Executive Management in Svitzer or their closely associated persons in Svitzer’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S in connection with APMH Invest A/S’ all-cash voluntary recommended purchase offer to acquire all issued shares of Svitzer, excluding any Svitzer treasury shares and shares held by APMH Invest A/S, on the terms set out in the offer document published by APMH Invest A/S on 2 April 2025.
About Svitzer
Svitzer is a leading, global towage and marine services provider. The core business is to assist large seaborne vessels in manoeuvring in and out of ports and terminals to berth and unberth. With around 450 vessels, Svitzer’s services play a crucial role as part of critical port infrastructure. Svitzer was founded in 1833 and serves approximately 2,000 customers in more than 140 ports and 40 terminals across 37 countries. Read more on www.svitzer.com.
For further information, please contact:
Michael Nass Nielsen, Head of Investor Relations and FP&A
T: +45 24941654
Attachments
- Company announcement - PDMR
- PDMR notification for APMH Invest AS
- PDMR notification for Robert M. Uggla
- PDMR notification for Knud Lind Winkler
- PDMR notification for Kasper Friis Nilaus
- PDMR notification for Morten H. Engelstoft
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Junshi Biosciences7.9.2025 14:30:00 CEST | Press release
Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints
KOORUI7.9.2025 06:24:16 CEST | Press release
HKC Group Enters Europe at IFA 2025 with Three Brands and Three World Premieres
Northland Power Inc.5.9.2025 23:59:34 CEST | Press release
Northland Power Announces Retirement of John Brace and Appointment of Sébastien Clerc to Its Board of Directors
DBV Technologies S.A.5.9.2025 22:30:00 CEST | Press release
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Vaisala Group5.9.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 5.9.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom